Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 16 | 2025 | 723 | 2.320 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 6 | 2025 | 26 | 1.400 |
Why?
|
| HIV Infections | 7 | 2025 | 972 | 0.980 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 8 | 2012 | 58 | 0.770 |
Why?
|
| Membrane Proteins | 4 | 2025 | 899 | 0.590 |
Why?
|
| Gene Products, gag | 2 | 2015 | 67 | 0.530 |
Why?
|
| Virus Release | 3 | 2012 | 14 | 0.470 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1185 | 0.460 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 2014 | 1 | 0.430 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2014 | 6 | 0.420 |
Why?
|
| Moloney murine leukemia virus | 1 | 2014 | 17 | 0.420 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 281 | 0.420 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 58 | 0.400 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 429 | 0.400 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2013 | 133 | 0.390 |
Why?
|
| Vesicular Transport Proteins | 3 | 2009 | 113 | 0.370 |
Why?
|
| Multiprotein Complexes | 2 | 2011 | 154 | 0.350 |
Why?
|
| Cell Line | 7 | 2023 | 2041 | 0.320 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2009 | 220 | 0.310 |
Why?
|
| Endosomes | 2 | 2012 | 177 | 0.290 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 674 | 0.290 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2008 | 38 | 0.270 |
Why?
|
| Pyrimidinones | 2 | 2004 | 16 | 0.260 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 92 | 0.260 |
Why?
|
| Ritonavir | 2 | 2004 | 18 | 0.260 |
Why?
|
| Protein Binding | 6 | 2012 | 1603 | 0.250 |
Why?
|
| Virus Replication | 5 | 2025 | 321 | 0.230 |
Why?
|
| ADAM10 Protein | 1 | 2025 | 11 | 0.230 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.220 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 395 | 0.220 |
Why?
|
| Protein Transport | 4 | 2015 | 403 | 0.210 |
Why?
|
| Oxazines | 1 | 2003 | 13 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2023 | 669 | 0.200 |
Why?
|
| Drug Monitoring | 1 | 2003 | 121 | 0.190 |
Why?
|
| Carrier Proteins | 1 | 2007 | 707 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 3 | 2015 | 262 | 0.190 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 154 | 0.180 |
Why?
|
| HEK293 Cells | 4 | 2025 | 622 | 0.170 |
Why?
|
| Virion | 2 | 2025 | 121 | 0.170 |
Why?
|
| Antigens, CD | 2 | 2012 | 347 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2007 | 1515 | 0.150 |
Why?
|
| Humans | 18 | 2025 | 63527 | 0.150 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 2 | 2009 | 4 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2025 | 642 | 0.130 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2016 | 12 | 0.130 |
Why?
|
| Germinal Center | 1 | 2016 | 39 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2018 | 277 | 0.130 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 71 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2016 | 173 | 0.120 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 90 | 0.120 |
Why?
|
| Leukemia Virus, Murine | 1 | 2015 | 30 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 99 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 1590 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1993 | 0.110 |
Why?
|
| Mutation | 4 | 2012 | 2615 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2015 | 317 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2015 | 310 | 0.110 |
Why?
|
| Gene Products, nef | 1 | 2014 | 13 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2016 | 208 | 0.110 |
Why?
|
| Glycosylation | 1 | 2014 | 137 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2012 | 345 | 0.100 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2012 | 21 | 0.090 |
Why?
|
| Alleles | 1 | 2013 | 447 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 695 | 0.090 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2011 | 17 | 0.090 |
Why?
|
| Binding Sites | 3 | 2012 | 906 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2011 | 410 | 0.080 |
Why?
|
| Protein Structure, Secondary | 4 | 2012 | 260 | 0.080 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 432 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2008 | 68 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 153 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 498 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2008 | 106 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 424 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2007 | 39 | 0.060 |
Why?
|
| Lopinavir | 2 | 2004 | 5 | 0.060 |
Why?
|
| Models, Biological | 2 | 2009 | 1182 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 612 | 0.060 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2025 | 28 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 429 | 0.050 |
Why?
|
| Antiviral Agents | 2 | 2023 | 322 | 0.050 |
Why?
|
| Mice | 2 | 2016 | 10863 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2003 | 11 | 0.050 |
Why?
|
| Alkynes | 1 | 2003 | 24 | 0.050 |
Why?
|
| Reference Standards | 1 | 2003 | 73 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 103 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2003 | 50 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 230 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2023 | 149 | 0.050 |
Why?
|
| Animals | 3 | 2016 | 20715 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2012 | 1150 | 0.040 |
Why?
|
| GPI-Linked Proteins | 2 | 2012 | 40 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1151 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 1664 | 0.040 |
Why?
|
| Interleukins | 1 | 2016 | 80 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 208 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 460 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 325 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 566 | 0.030 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2166 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 99 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2113 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 100 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 129 | 0.020 |
Why?
|
| Scattering, Small Angle | 1 | 2010 | 16 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 108 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 92 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 248 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3401 | 0.020 |
Why?
|
| Acids | 1 | 2006 | 14 | 0.020 |
Why?
|
| Amino Acids, Acidic | 1 | 2006 | 1 | 0.020 |
Why?
|
| Amino Acids, Basic | 1 | 2006 | 1 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 145 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 173 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 167 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 363 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 265 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 490 | 0.010 |
Why?
|
| Food-Drug Interactions | 1 | 2004 | 4 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2004 | 19 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 165 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 299 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 369 | 0.010 |
Why?
|
| Male | 2 | 2012 | 29931 | 0.010 |
Why?
|
| Female | 2 | 2012 | 32939 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 3708 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 16895 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 17656 | 0.000 |
Why?
|